Stan and Rosanne Crooke launch n-Lorem by Mark Zipkin "Biotech millionaire funds free drugs for ultr | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  14062 of 14098  at  1/31/2020 12:50:58 PM  by

pineappleguava


Stan and Rosanne Crooke launch n-Lorem by Mark Zipkin "Biotech millionaire funds free drugs for ultra-rare diseases" Jan. 24, 2020

Just read this article posted on the IV IONS Board by "arthurs1".
It is worth reading in its entirety in my opinion.  
 
 
Just a snippet from article
 
"Testing requirements for ultra-rare disease therapies like the ASOs pursued by n-Lorem will have implications beyond just a handful of patients. In an editorial accompanying Yu’s paper, Janet Woodcock, and Peter Marks from the FDA’s Center for Drug Evaluation and Research, wrote that “programs for a single patient are likely to set the floor for the minimum preclinical evaluation.” They added that although in the near term ultra-rare therapies could exist as investigational drugs only, regulatory approval would become more pertinent if similar interventions begin to proliferate.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 173
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...